Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipelineHighlights InstaDeep’s new near ...
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...
One expert in Indiana expects to see another wave of COVID-19 infections during late spring based on past patterns.
A good chunk of your paycheck goes to medical insurance. Know your options. Prudent action and planning maximize every dollar ...
The updated formulation pertains to both approved (Comirnaty and Spikevax) and authorized (Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine) mRNA vaccines. The 2024-2025 mRNA COVID-19 ...
TORONTO — The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus ...
A head-to-head study has revealed that CSL and Arcturus Therapeutic’s self-amplifying mRNA vaccine can maintain a stronger immune response than a conventional mRNA vaccine for up to one year and at a ...
Kong Dog, the dynamic and innovative culinary sensation known for reinventing Korean-style corn dogs and creative street food, proudly announced ...
The rising global incidence of breast cancer, driven by lifestyle changes and an aging population, is a key market driver. Technological advancements in diagnostics and treatment, such as molecular ...
Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace ...
Yara International ASA third quarter 2024 results will be published on Friday, 25 October 2024 at 08:00 CEST.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback